January 5, 2009 — Adjuvant chemotherapy reduces recurrences and improves disease-free survival at five years for patients with early breast cancer who have isolated tumor cells or nodal micrometastases detected upon sentinel lymph node dissection. These results were recently presented at the 2008 annual San Antonio Breast Cancer Symposium.

January 5, 2009 — Researchers from the United States and Canada reported that the fully human monoclonal antibody, denosumab (Amgen), consistently increases bone mineral density (BMD) in women with non-metastatic breast cancer receiving long-term treatment with aromatase inhibitors. These results were presented at the 2008 annual San Antonio Breast Cancer Symposium (SABCS) December 10-14, 2008.

January 5, 2009 — In a study of close to 8,000 women, supplementation with vitamin C, vitamin E, or beta carotene did not reduce the risk of developing or dying of cancer. These results were published in the Journal of the National Cancer Institute.